NIH-funded research R21 grant

Reducing severe problem behaviors in individuals with intellectual disabilities

Official title: A Single-Arm Pilot trial for Mitigating Relapse of Severe Problem Behavior

Funded at Auburn University at Auburn · NIH-10885635 · Data updated 2026-11-12

This study is looking at ways to help people with intellectual and developmental disabilities who struggle with serious behaviors like self-injury and aggression, by using special communication training to make it easier for them to express their needs and feelings.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAuburn University at Auburn
NIH-funded
Lab location1 site (Auburn, UNITED STATES)
Project startSeptember 1, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$213,209
NIH project number1R21HD112724-01A1
Project IDNIH-10885635 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with intellectual and developmental disabilities who exhibit severe problem behaviors.

Less likely to help

Patients who do not have intellectual or developmental disabilities or who do not exhibit severe problem behaviors may not benefit from this research.

What this research studies

This research investigates effective methods to reduce severe problem behaviors, such as self-injury and aggression, in individuals with intellectual and developmental disabilities (IDD). The approach focuses on behavior-analytic treatments, particularly functional communication training, which is implemented in specialized settings by trained staff. The study aims to address challenges that lead to relapse of these behaviors when treatment is generalized to new environments or when alternative reinforcements are diminished. By understanding these relapse phenomena, the research seeks to improve the long-term effectiveness of behavioral interventions.

Why it matters

Potential benefit: If successful, this research could lead to more effective strategies for managing severe problem behaviors, improving the quality of life for individuals with IDD.

How similar studies have gone: Previous research has shown that behavior-analytic treatments can be effective in reducing severe problem behaviors, but this specific approach to addressing relapse is novel.

Where this research is happening

  • Auburn University at Auburn
    Auburn, United States
    Active

Researchers

  • Principal investigator: Falligant, John — Auburn University at Auburn
  • Study coordinator: Falligant, John

Related research

Other NIH-funded projects on the same topics.

  • Social stress and smoking: why disadvantaged young adults struggle to quit

    This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11540695

  • Learning from remission and relapse in lupus (SLE)

    Researchers are studying people with systemic lupus erythematosus who are in long-term remission without steroids or immunosuppressants to understand their immune cells, brain function, and what might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513534

  • Learning from Remission and Relapse in SLE

    A program to study people with systemic lupus erythematosus who are in long-term remission to understand immune and brain signals that might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513533

  • Alternative NF-kB activation after chemotherapy in ovarian cancer

    This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

    NIH research San Diego State University · San Diego, United States · NIH-11473227

  • Predictors of autoimmunity onset and relapse in skin

    A study to understand what biological signals in skin predict when autoimmune diseases start, flare, or worsen in people at risk.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11471389

  • Determinants of TB Control, Relapse, and Reinfection

    A large, multi-year study aims to understand why some people who are treated for TB still have persistent infection or relapse, with the goal of improving prevention and treatment.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11449646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.